Company intelligence / Profile preview

Anaut

Tokyo, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Eureka α demonstrated reliable real-time visual recognition of connective tissue, pancreas, and vascular structures in laparoscopic/robotic surgeries, significantly aiding surgical navigation and accuracy. Clinical studies show improved sensitivity/precision and surgeon confidence, and regulatory approval in Japan in 2024—no equivalent clinical devices approved internationally

Therapeutic areas: Women's HealthOncologyGastroenterologyMen's Health
Modalities: DeviceArtificial intelligenceDeep learningComputer vision
Industry: Digital Health Medical Devices

Partnerships

Over 20 Japanese academic research institutions and medical university hospitalspublic entity support: Tokyo Metropolitan Government, NEDO, JETRO, Kawasaki City

Beyond the preview

Go deeper on Anaut.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anaut.

Explore the full profile